Ginkgo biloba extract for promoting blood flow and preparation method of ginkgo biloba extract

Through supercritical CO2 extraction and enzyme preparation combined with macroporous resin adsorption technology, the content of flavonol glycosides in ginkgo leaf extract was improved, and the problems of high production costs and low active ingredients in the existing technology were solved, thus achieving suitable industrial production efficient extraction effect and significantly improve hemorigics.

CN118987058AActive Publication Date: 2024-11-22ZHEJIANG XINCHANG NATURAL HEALTH PROD CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411015024.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-26
Publication Date
2024-11-22
Estimated Expiration
2044-07-26

AI Technical Summary

Technical Problem

The existing ginkgo leaf extract process has high production costs, great environmental impact, low active ingredients content, and difficult to achieve industrial production.

Method used

The supercritical CO2 extraction binding enzyme preparation and macroporous resin adsorption technology are used to extract the enzyme preparations of β-glucosidase, amino acid oxidase and α-amylase to increase the content of flavonol glycosides and pass the specific proportion of fogpes. Optimized extracts for ratios of cinnamon, kaempferol and isobacterin.

Benefits of technology

It significantly improves the extraction yield of flavonol glycosides in ginkgo leaf extract, reduces production costs, improves the separation efficiency of active ingredients, and realizes a high content of ginkgo leaf extract, which is suitable for industrial production, and significantly improves blood rheology. Learn the effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004965458610000051
    Figure BDA0004965458610000051
  • Figure BDA0004965458610000061
    Figure BDA0004965458610000061
  • Figure BDA0004965458610000072
    Figure BDA0004965458610000072
Patent Text Reader

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a ginkgo biloba extract for promoting blood flow and a preparation method of the ginkgo biloba extract. The preparation method of the ginkgo biloba extract comprises the following steps: (1) crushing ginkgo biloba, carrying out supercritical CO2 extraction, and collecting the extract to obtain a crude extract; (2) mixing the crude extract, an enzyme preparation and water, and standing to obtain enzymatic hydrolysate; and (3) finally, adsorbing and eluting the enzymatic hydrolysate through X-5 macroporous resin, and drying to obtain the enzyme preparation which is a mixture of beta-glucosidase, amino acid oxidase and alpha-amylase. An enzyme preparation of beta-glucosidase, amino acid oxidase and alpha-amylase in a specific proportion is mixed with the crude extract, the content of flavonol glycosides in the ginkgo biloba extract is increased, flavonol glycosides comprise quercetin, kaempferol and isorhamnetin in a specific proportion, and hematology can be remarkably improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medicine, and in particular relates to a ginkgo leaf extract for promoting blood flow and a preparation method thereof. Background Art

[0002] Ginkgo biloba is one of the oldest plants on earth, with unique pharmacological effects and therapeutic value. Ginkgo biloba extract contains flavonoids, terpenoids, polyphenols, organic acids, polyisoprenols and other trace elements, etc., which have antioxidant effects, anti-platelet activating factor effects, blood lipid and blood sugar lowering effects, improve heart and brain blood circulation, and have clinical effects on the central nervous system, digestive system, respiratory system, etc. Among them, ginkgolides and ginkgo flavonoids are the main active ingredients in ginkgo biloba extract. Ginkgolides are diterpenoid ester compounds, including ginkgolides A, B, C, J and M (GKA, GKB, GKC, GKJ, GKM), etc. Clinical and pharmacological studies have shown that ginkgo flavonoids can dilate capillaries and increase blood flow in the skin. Ginkgolides have a specific antagonistic effect on platelet activating factor, and can inhibit inflammation and pruritus caused by platelet activating factor. Ginkgo leaf extract has the effects of enhancing cardiac function, improving microcirculation, reducing blood viscosity, antagonizing platelet activation factor, scavenging free radicals in the body and significantly dissolving fibrinogen, and enhancing the heart's tolerance to ischemia.

[0003] The reported ginkgo leaf extract processing technologies include: enzyme method, hot soaking method, microwave extraction method, carbon dioxide supercritical extraction method, water or organic solvent method, etc.

[0004] Chinese invention patent application CN106176838A discloses a method for producing a ginkgo leaf extract, which comprises the following steps: crushing the raw material, and then filling a chromatography column with a diameter-to-height ratio of 1:3-5; extracting ethyl acetate by countercurrent flow from the lower end to the upper end of the chromatography column under pressure to obtain an extract; vacuum concentrating the extract; extracting the concentrate with 4-6 times the weight of the raw material with distilled water, adding 2-4% diatomaceous earth by weight of the raw material, filtering to obtain a filtrate; applying a macroporous adsorption resin to the filtrate, the resin volume: the weight of the raw material (L:kg) = 1:3-5, and then analyzing with 3BV mass concentration 60-70% ethanol to obtain an analytical solution, adding a mixture of activated carbon, gelatin, and diatomaceous earth, fully stirring, cooling, centrifugal filtering, concentrating and drying to obtain a finished product. The ginkgo leaf extract produced by the present invention has flavonol glycosides ≥30%, ginkgolides ≥9%, and ginkgolic acid ≤1ppm.

[0005] Another Chinese invention patent application CN106038619A discloses a ginkgo leaf extract and a preparation method thereof, comprising the following steps: (1) preparation of ginkgo leaf powder: removing impurities from the ginkgo leaf and drying it, crushing the dried ginkgo leaf and sieving it; (2) supercritical CO2 extraction: adding the ginkgo leaf powder obtained in step (1) into a CO2 supercritical extractor, adding anhydrous ethanol as an entrainer, and performing supercritical extraction. After the extraction is completed, collecting the extract to obtain a ginkgo leaf crude extract solution; (3) pretreatment of the ginkgo leaf crude extract: filtering the ginkgo leaf crude extract solution, concentrating it, diluting it with an ethanol solution, cooling it at 3-5°C for 10-14 hours, filtering it again to obtain a column liquid; (4) macroporous resin purification: passing the column liquid through an AB-8 resin column, first eluting it with pure water, then eluting it with an ethanol solution to analyze the resin column, and collecting the eluate; (5) drying the ginkgo leaf extract into powder: concentrating the eluate by rotary evaporation, and vacuum drying it to obtain a ginkgo leaf extract powder product.

[0006] However, the main problems with the above technologies are: high production cost, great impact on the environment, low content of extracted effective ingredients, unreasonable process routes and difficulty in achieving large-scale industrial production.

[0007] Therefore, there is an urgent need to provide a preparation process for ginkgo leaf extract that has a high content of active ingredients, is environmentally friendly and is suitable for industrial production. Summary of the invention

[0008] The invention aims at solving the problems in the prior art and provides a ginkgo leaf extract for promoting blood flow and a preparation method thereof.

[0009] A method for preparing a ginkgo leaf extract for promoting blood flow comprises the following steps:

[0010] (1) firstly crush the ginkgo leaves, extract them through supercritical CO2, collect the extracts, and obtain the crude extract of ginkgo leaves;

[0011] (2) mixing the crude ginkgo leaf extract, the enzyme preparation and water, and allowing to stand to obtain an enzymatic solution;

[0012] (3) Finally, the enzymatic hydrolyzate is adsorbed and eluted by X-5 macroporous resin and dried to obtain:

[0013] Wherein, the enzyme preparation in step (2) is a mixture of β-glucosidase, amino acid oxidase and α-amylase.

[0014] Preferably, the entrainer for the supercritical CO2 extraction in step (1) is an ethanol aqueous solution with a volume fraction of 30-40%, the extraction pressure is 15-25 MPa, the extraction temperature is 40-50°C, and the extraction time is 2-3h.

[0015] Preferably, the mass volume ratio of the ginkgo leaf to the entrainer is 1 g:10-20 mL.

[0016] Preferably, the enzyme preparation in step (2) is a mixture of β-glucosidase, amino acid oxidase and α-amylase in a mass ratio of 1-3:1-3:1-2, the standing time is 6-8h, and the standing temperature is 30-50°C.

[0017] Preferably, the mass volume ratio of the crude ginkgo leaf extract, the enzyme preparation and water in step (2) is 1 g: 0.001-0.005 g: 2-6 mL.

[0018] Preferably, the adsorption elution in step (3) comprises eluting with 1-3 column volumes of water, and then eluting with 3-6 column volumes of 45-55% ethanol solution, collecting the ethanol eluate, and the elution flow rate is 1-3 mL / min.

[0019] Preferably, before drying in step (3), the product needs to be concentrated under reduced pressure to a solid content of 60-70%, the drying temperature is 80-90° C., and the drying time is 12-24 h.

[0020] The present invention also provides a ginkgo leaf extract prepared by the above preparation method. In terms of mass percentage, the total flavonol glycoside content of the ginkgo leaf extract is ≥24%, the total terpenoid lactone content is 6-8%, and the total ginkgolic acid content is less than 1ppm.

[0021] Preferably, the peak area ratio of quercetin, kaempferol and isorhamnetin in the total flavonol glycosides is 0.9-1.1:1:0.5-0.8.

[0022] The present invention also provides a health product for promoting blood flow, comprising the ginkgo leaf extract prepared by the above preparation method, and the dosage form of the health product is tablets, capsules or granules.

[0023] The present invention also provides the use of the ginkgo leaf extract prepared by the preparation method in preparing health products or medicines for promoting blood flow.

[0024] Compared with the prior art, the present invention has the following beneficial effects:

[0025] (1) In the process of preparing the extract, the present invention selects 30-40% ethanol aqueous solution as the entrainer for supercritical CO2 extraction, which greatly improves the extraction yield of flavonol glycosides in the ginkgo leaf extract and reduces the production cost.

[0026] (2) The present invention uses an enzyme preparation of β-glucosidase, amino acid oxidase and α-amylase in a specific ratio to increase the content of flavonol glycosides in the ginkgo leaf extract and obtain a ginkgo leaf extract with a specific content ratio of quercetin, kaempferol and isorhamnetin.

[0027] (3) The present invention uses X-5 macroporous resin to purify and separate the ginkgo leaf hydrolysate, thereby effectively increasing the separation efficiency of the effective components in the hydrolysate and improving the extraction efficiency of flavonol glycosides in the ginkgo leaf extract.

[0028] (4) The present invention provides a ginkgo leaf extract for promoting blood flow. The main components of the flavonol glycosides in the extract include quercetin, kaempferol and isorhamnetin. By using a specific ratio of the three, the effect of significantly improving blood rheology can be achieved. DETAILED DESCRIPTION

[0029] It is worth noting that the raw materials used in the present invention are all common commercially available products, among which ethanol is analytically pure and purchased from Aladdin; n-hexane is analytically pure and purchased from Aladdin; β-glucosidase, CAS No. 9001-22-3, purchased from Shanghai Yuanye Biotechnology Co., Ltd.; amino acid oxidase is D-amino acid oxidase, CAS No. 9000-88-8, purchased from Shanghai Yuanye Biotechnology Co., Ltd.; α-amylase, CAS No. 9000-90-2, purchased from Aladdin.

[0030] Example 1

[0031] A method for preparing a ginkgo leaf extract for promoting blood flow comprises the following steps:

[0032] (1) First, grind the ginkgo leaves and pass them through an 80-mesh sieve to obtain ginkgo leaf powder.

[0033] (2) The ginkgo leaf powder was then mixed with an entrainer at a mass volume ratio of 1 g:15 mL (the entrainer was an ethanol aqueous solution with a volume fraction of 40%), and added to a CO2 supercritical extractor. Supercritical extraction was performed at an extraction pressure of 20 MPa and an extraction temperature of 45°C. The extraction time was 2.5 h and the CO2 flow rate was 20 L / h. After the extraction was completed, a crude ginkgo leaf extract was obtained.

[0034] (3) The crude ginkgo leaf extract, enzyme preparation and water were evenly mixed in a mass volume ratio of 1 g:0.003 g:3 mL, and allowed to stand at 40° C. for 7 h to obtain an enzymatic hydrolyzate, wherein the enzyme preparation was a mixture of β-glucosidase, amino acid oxidase and α-amylase in a mass ratio of 2:2:1.5.

[0035] (4) Finally, the enzymatic hydrolyzate was first adsorbed by X-5 macroporous adsorption resin, then eluted with 2 column volumes of purified water, and then eluted with 4 column volumes of 50% ethanol solution, and the ethanol eluate was collected at a flow rate of 2 mL / min, concentrated under reduced pressure to a solid content of 70%, and dried at 85° C. for 18 h to obtain the ginkgo leaf extract.

[0036] Example 2

[0037] A method for preparing a ginkgo leaf extract for promoting blood flow comprises the following steps:

[0038] (1) First, grind the ginkgo leaves and pass them through an 80-mesh sieve to obtain ginkgo leaf powder.

[0039] (2) The ginkgo leaf powder was mixed with an entrainer at a mass volume ratio of 1 g:10 mL (the entrainer was an ethanol aqueous solution with a volume fraction of 30%), and added to a CO2 supercritical extractor. Supercritical extraction was performed at an extraction pressure of 15 MPa and an extraction temperature of 40°C. The extraction time was 2 h and the CO2 flow rate was 15 L / h. After the extraction was completed, a crude ginkgo leaf extract was obtained.

[0040] (3) The crude ginkgo leaf extract, the enzyme preparation and water were evenly mixed in a mass volume ratio of 1 g:0.001 g:2 mL, and allowed to stand at 30° C. for 8 h to obtain an enzymatic hydrolyzate, wherein the enzyme preparation was a mixture of β-glucosidase, amino acid oxidase and α-amylase in a mass ratio of 1:1:1.

[0041] (4) Finally, the enzymatic hydrolyzate was first adsorbed by X-5 macroporous adsorption resin, then eluted with 3 column volumes of purified water, and then eluted with 3 column volumes of 45% ethanol solution, and the ethanol eluate was collected at a flow rate of 2 mL / min, concentrated under reduced pressure to a solid content of 60%, and dried at 80° C. for 24 h to obtain the ginkgo leaf extract.

[0042] Example 3

[0043] A ginkgo leaf extract to promote blood flow, the steps are as follows:

[0044] (1) First, grind the ginkgo leaves and pass them through an 80-mesh sieve to obtain ginkgo leaf powder.

[0045] (2) The ginkgo leaf powder was mixed with an entrainer at a mass volume ratio of 1 g:20 mL (the entrainer was an ethanol aqueous solution with a volume fraction of 30%), and added to a CO2 supercritical extractor. Supercritical extraction was performed at an extraction pressure of 25 MPa and an extraction temperature of 50°C. The extraction time was 2 h and the CO2 flow rate was 20 L / h. After the extraction was completed, a crude ginkgo leaf extract was obtained.

[0046] (3) The crude ginkgo leaf extract, the enzyme preparation and water were evenly mixed in a mass volume ratio of 1 g:0.005 g:6 mL, and allowed to stand at 50° C. for 6 h to obtain an enzymatic hydrolyzate, wherein the enzyme preparation was a mixture of β-glucosidase, amino acid oxidase and α-amylase in a mass ratio of 3:3:2.

[0047] (4) Finally, the enzymatic hydrolyzate is first adsorbed by X-5 macroporous adsorption resin, then eluted with 1 column volume of purified water, and then eluted with 6 column volumes of 50% ethanol solution, and the ethanol eluate is collected at a flow rate of 2 mL / min, concentrated under reduced pressure to a solid content of 70%, and dried at 90° C. for 12 h to obtain the ginkgo leaf extract.

[0048] Comparative Example 1

[0049] A method for preparing a ginkgo leaf extract for promoting blood flow, which is different from Example 1 only in that the entrainer for supercritical CO2 extraction in step (2) is an anhydrous ethanol solution.

[0050] Comparative Example 2

[0051] A method for preparing a ginkgo leaf extract for promoting blood flow, which is different from Example 1 only in that the enzyme preparation in step (3) is a mixture of β-glucosidase and α-amylase in a mass ratio of 1:1.

[0052] Comparative Example 3

[0053] A method for preparing a ginkgo leaf extract for promoting blood flow, which is different from Example 1 only in that the enzyme preparation in step (3) is a mixture of β-glucosidase, amino acid oxidase and α-amylase in a mass ratio of 5:4:1.

[0054] Comparative Example 4

[0055] A method for preparing a ginkgo leaf extract for promoting blood flow, which is different from Example 1 only in that X-5 macroporous resin is replaced by D101 macroporous resin in step (4).

[0056] Content determination

[0057] According to the content determination method of Ginkgo biloba extract in the 2020 edition of the "Chinese Pharmacopoeia", the terpene lactone and total ginkgolic acid contents of the ginkgo leaf extracts prepared in Examples 1-3 and Comparative Examples 1-4 were respectively determined, and the total ginkgolic acid content was calculated as heptadecanedemonide ginkgolic acid C17:1; using quercetin as a reference, the total flavonol glycosides were determined, and the peak area ratios of quercetin, kaempferol and isorhamnetin in the total flavonol glycosides were further determined. The results are shown in Table 1 below.

[0058] Table 1 Determination of the content of ginkgo leaf extracts prepared in Examples 1-3 and Comparative Examples 1-4

[0059]

[0060] Experiment 1: Effect of the Ginkgo biloba leaf extract of the present invention on hemorheology of hyperlipidemic rats

[0061] 1. Test samples: The Ginkgo biloba leaf extracts prepared in Examples 1-3 and Comparative Examples 1-4 of the present invention.

[0062] 2. Experimental animals: 90 ordinary-grade SD rats, male, weighing 200±20 g. Provided by Shanghai Xipu-Bikai Laboratory Animal Co., Ltd., license number: SCXK(Shanghai)2008-0016.

[0063] 3. Instruments and reagents: LIANG-100 type hemorheology analyzer; LIANG-100 type erythrocyte electrophoresis analyzer; DXC-300A type erythrocyte deformability analyzer; XJ-F type platelet aggregometer; TDL-5 cell separator for determination; 0.1% hydrochloric acid adrenaline, anesthetic chloral hydrate, anticoagulant sodium citrate.

[0064] 4. Experimental method: The rats were randomly divided into 9 groups, namely the control group, the model group, Examples 1-3 and Comparative Examples 1-4 groups, with 10 rats in each group. The groups of Examples 1-3 and Comparative Examples 1-4 were given the corresponding products by gavage (dosage 100 mg / kg·BW), and the model group and the control group were given an equal amount of normal saline by gavage for 7 consecutive days. Except for the control group, the remaining groups were subcutaneously injected with 0.1% hydrochloric acid adrenaline injection (0.5 mL / kg) 2 hours after administration on the 7th day, twice in total, with an interval of 5 hours; 5 minutes after the first injection, the rats were immersed in ice water for 5 minutes to make an acute blood stasis model. All animals were fasted but not water-deprived. After 18 hours, the rats were anesthetized with chloral hydrate at a mass concentration of 0.1 g / mL, and blood was collected by carotid artery intubation. 5 mL of blood was collected per rat, anticoagulated with sodium citrate at a mass concentration of 0.038 g / mL at a ratio of 1:9, and the indexes of whole blood (high shear, low shear) viscosity, plasma viscosity and hematocrit were measured.

[0065] 5. Experimental results: As shown in Table 2, compared with the control group, the whole blood (high shear, low shear) viscosity, plasma viscosity and hematocrit in the model group were significantly increased (P<0.05), indicating that the model was established. Compared with the model group, the Ginkgo biloba leaf extracts prepared in the present invention could significantly reduce the whole blood (high shear, low shear) viscosity, plasma viscosity and hematocrit of hyperlipidemic rats (P<0.05). From the experimental data of the examples and the comparative examples, it can be seen that by the specific ratio of quercetin, kaempferol and isorhamnetin, the effect of significantly improving hemorheology can be achieved. Among them, when the peak area ratio of quercetin, kaempferol and isorhamnetin in the total flavonol glycosides of the Ginkgo biloba leaf extract prepared in Example 1 was 1:1:0.8, the effect of improving hemorheology was the best (P<0.01).

[0066] Table 2 Changes of blood rheology in each group

[0067]

[0068]

[0069] Note: Compared with the model group, * indicates P < 0.05, ** Indicates P < 0.01; compared with the control group, # Indicates P<0.05.

[0070] Experiment 2 Effect of the Ginkgo Biloba Extract of the Present Invention on Hemorheology in Elderly Patients with Ischemic Cerebrovascular Disease

[0071] 1. Test samples: Ginkgo biloba extracts prepared in Example 1 of the present invention and Comparative Examples 1-4.

[0072] 2. Experimental subjects: The cases were selected according to the diagnostic reference standard of "Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China 2018". A total of 50 elderly patients with ischemic cerebrovascular disease were included, including 27 males and 23 females, aged 66-89 years, with a disease course of 5.8±3.8 years. Before treatment, abnormal blood rheology was found in all patients.

[0073] 3. Experimental method: 50 elderly patients with ischemic cerebrovascular disease were randomly divided into 5 groups, 10 in each group. The patients received basic antihypertensive, lipid-lowering and antithrombotic drug treatment for 7 days. In addition to the basic treatment, 50 mg of ginkgo leaf extract prepared in Example 1 of the present invention and Comparative Examples 1-4 were given, dissolved in 250 mL of 0.9% sodium chloride injection (purchased from Sichuan Pacific Pharmaceutical Co., Ltd.), and slowly dripped intravenously, once / d, for 7 consecutive days. Tianhai fully automatic blood rheology analyzer (MVIS-2035) was used to detect whole blood high shear viscosity, whole blood low shear viscosity and plasma viscosity, and fully automatic blood cell analyzer was used to detect hematocrit and reticulocytes. SPSS23.0 statistical software was used to process the data, and P<0.05 was considered statistically significant.

[0074] 4. Experimental results: As shown in Table 3, after taking the ginkgo leaf extracts prepared in Example 1 and Comparative Examples 1-4, the whole blood high shear viscosity, whole blood low shear viscosity, plasma viscosity, and reticulocytes were all lower than before treatment, among which, the differences in the data of Example 1 were statistically significant (P<0.05), indicating that the ginkgo leaf extract prepared by the present invention has the effect of reducing blood viscosity and improving blood rheology in elderly patients with ischemic cerebrovascular disease.

[0075] Table 3 Comparison of blood rheology before and after treatment

[0076]

[0077]

[0078] Note: * Compared with before treatment, P<0.05.

[0079] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, rather than to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions of the technical solution of the present invention by ordinary technicians in this field do not deviate from the essence and scope of the technical solution of the present invention.

Claims

1. A method for preparing a ginkgo leaf extract for promoting blood flow, characterized in that: The following steps are involved: (1) firstly crush the ginkgo leaves, extract them through supercritical CO2, collect the extracts, and obtain the crude extract of ginkgo leaves; (2) mixing the crude ginkgo leaf extract, the enzyme preparation and water, and allowing to stand to obtain an enzymatic solution; (3) Finally, the enzymatic hydrolyzate is adsorbed and eluted by X-5 macroporous resin and dried to obtain: Wherein, the enzyme preparation in step (2) is a mixture of β-glucosidase, amino acid oxidase and α-amylase.

2. The preparation method according to claim 1, characterized in that: The entrainer for the supercritical CO2 extraction in step (1) is an ethanol aqueous solution with a volume fraction of 30-40%, the extraction pressure is 15-25MPa, the extraction temperature is 40-50°C, and the extraction time is 2-3h.

3. The preparation method according to claim 2, characterized in that: The mass volume ratio of the ginkgo leaf to the entrainer is 1g:10-20mL.

4. The preparation method according to claim 1, characterized in that: The enzyme preparation in step (2) is a mixture of β-glucosidase, amino acid oxidase and α-amylase in a mass ratio of 1-3:1-3:1-2, the standing time is 6-8h, and the standing temperature is 30-50°C.

5. The preparation method according to claim 1, characterized in that: The mass volume ratio of the crude ginkgo leaf extract, the enzyme preparation and water in step (2) is 1 g: 0.001-0.005 g: 2-6 mL.

6. The preparation method according to claim 1, characterized in that: The adsorption elution in step (3) includes eluting with 1-3 column volumes of water, and then eluting with 3-6 column volumes of 45-55% ethanol solution, collecting the ethanol eluate, and the elution flow rate is 1-3 mL / min.

7. The preparation method according to claim 1, characterized in that: Before drying in step (3), the product needs to be concentrated under reduced pressure to a solid content of 60-70%, the drying temperature is 80-90° C., and the drying time is 12-24 hours.

8. A ginkgo leaf extract prepared by the preparation method according to any one of claims 1 to 7, characterized in that: In terms of mass percentage, the total flavonol glycoside content in the ginkgo leaf extract is ≥24%, the total terpenoid lactone content is 6-8%, the total ginkgolic acid content is less than 1ppm, and the peak area ratio of quercetin, kaempferol and isorhamnetin in the total flavonol glycosides is 0.9-1.1:1:0.5-0.

8.

9. A health product for promoting blood flow, characterized in that: The health product comprises the ginkgo leaf extract prepared by the preparation method according to any one of claims 1 to 7 or the ginkgo leaf extract according to claim 8, wherein the dosage form of the health product is tablets, capsules or granules.

10. Use of the ginkgo leaf extract obtained by the preparation method according to any one of claims 1 to 7 or the ginkgo leaf extract according to claim 8 in the preparation of a health product or medicine for promoting blood flow.

Citation Information

Patent Citations

  • Technological method for efficiently extracting ginkgo flavone

    CN104906153A

  • Method for efficiently extracting flavone from ginkgo leaves and converting flavone into aglycon flavone

    CN107158048A